Fastin-XR

FDA Disclaimer Statement

THESE STATEMENTS HAVE NOT BEEN APPROVED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.

Precautions re: All Other

INDIVIDUALS WHO CONSUME CAFFEINE WITH THIS PRODUCT MAY EXPERIENCE SERIOUS ADVERSE HEALTH EFFECTS. INDIVIDUALS WHO ARE SENSITIVE TO THE EFFECTS OF CAFFEINE SHOULD CONSULT A LICENSED HEALTH CARE PROFESSIONAL BEFORE CONSUMING THIS PRODUCT. (WARNING.INFORMATION CONTINUED ON BACK OF LABEL.)

Precautions re: All Other

IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. AVOID ALCOHOL WHILE TAKING THIS PRODUCT. DO NOT EXCEED RECOMMENDED SERVING. EXCEEDING RECOMMENDED SERVING MAY CAUSE SERIOUS ADVERSE HEALTH EFFECTS, INCLUDING HEART ATTACK AND STROKE. DISCONTINUE USE AND CALL A PHYSICIAN OR LICENSED QUALIFIED HEALTH CARE PROFESSIONAL IMMEDIATELY IF YOU EXPERIENCE RAPID HEARTBEAT, DIZZINESS, SEVERE HEADACHE, SHORTNESS OF BREATH, OR OTHER SIMILAR SYMPTOMS. IMPROPER USE OF THIS PRODUCT MAY BE HAZARDOUS TO A PERSON'S HEALTH. EXCEEDING RECOMMENDED SERVING WILL NOT IMPROVE RESULTS.

Seals/Symbols

HTP HI-TECH PHARMACEUTICALS

FDA Statement of Identity

DIETARY SUPPLEMENT

General Statements: All Other Content

EXTENDED RELEASE CAPSULES

General Statements: All Other Content

THE WORLD'S MOST ADVANCED WEIGHT LOSS AID EVER DEVELOPED WITH EXTENDED RELEASE TECHNOLOGY!

General Statements: All Other Content

REVOLUTIONARY FAT LOSS CATALYST & APOPTOSIS AGENT

Suggested/Recommended/Usage/Directions

Dosage: Take 1-2 capsules in the morning and 1 capsule after lunch. Do not exceed 4 capsules daily.

Precautions re: Children

WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS.

Precautions re: Pregnant or Nursing or Prescription Medications

DO NOT USE IF YOU ARE PREGNANT OR NURSING.

Precautions re: Children

SALE TO PERSONS 17 YEARS OF AGE OR YOUNGER IS PROHIBITED

Precautions re: All Other

Tamper Evident Do Not Use If Printed Seal Is Cut, Torn or Missing

General Statements: All Other Content

PEEL HERE

General Statements: All Other Content

525 mg

General Statements: All Other Content

To report adverse effects call FDA's MedWatch at 1.800.332.1088